Cresco Labs (CRLBF) EPS (Basic) (QoQ) (2020 - 2026)
Cresco Labs (CRLBF) EPS (Basic) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.84% |
| Dec 31, 2025 | -394.38% |
| Sep 30, 2025 | -5.47% |
| Jun 30, 2025 | -11.88% |
| Mar 31, 2025 | -351.02% |
| Dec 31, 2024 | 154.09% |
| Sep 30, 2024 | 80.78% |
| Jun 30, 2024 | -879.70% |
| Mar 31, 2024 | -298.06% |
| Dec 31, 2023 | 102.38% |
| Sep 30, 2023 | -193.99% |
| Jun 30, 2023 | -36.26% |
| Mar 31, 2023 | 84.20% |
| Dec 31, 2022 | -1,564.66% |
| Sep 30, 2022 | 28.87% |
| Jun 30, 2022 | -148.85% |
| Mar 31, 2022 | 103.93% |
| Dec 31, 2021 | -193.97% |
| Sep 30, 2021 | -4,462.37% |
| Jun 30, 2021 | -84.99% |